Shujuan Lv
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Retraction notice to "Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis" [Biomedicine & Pharmacotherapy 82 (2016) 669-676].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 08, 2026
Retraction notice to "Gypsophila elegans isoorientin attenuates CCl4-induced hepatic fibrosis in rats via modulation of NF-κB and TGF-β1/Smad signaling pathways" [Int. Immunopharmacol. 28(1) (2015) 305-312].
Journal: International immunopharmacology
Published: September 09, 2025
Corrigendum to "Gypsophila elegans isoorientin-2″-O-α-L-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation" [Int. Immunopharmacol. 54 (2018) 60-67].
Journal: International immunopharmacology
Published: July 27, 2023
Corrigendum to "Pratensein attenuates Aβ-induced cognitive deficits in rats: Enhancement of synaptic plasticity and cholinergic function" [Fitoterapia 101 (2015) 208-217].
Journal: Fitoterapia
Published: January 11, 2022
Corrigendum to "Antiviral activity of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) against hepatitis B virus" [Antiviral Res. 100 (2013) 373-381].
Journal: Antiviral research
Published: January 24, 2021
Corrigendum to "Protective effect of madecassoside against cognitive impairment induced by D-galactose in mice" [Pharmacol. Biochem. Behav. 124 (2014) 434-442].
Journal: Pharmacology, biochemistry, and behavior
Published: December 28, 2020
Gypsophila elegans isoorientin-2″-O-α-l-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation.
Journal: International immunopharmacology
Published: September 01, 2017
Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 12, 2016
Gypsophila elegans isoorientin attenuates CCl₄-induced hepatic fibrosis in rats via modulation of NF-κB and TGF-β1/Smad signaling pathways.
Journal: International immunopharmacology
Published: April 29, 2015
Protective effect of genistein on lipopolysaccharide/D-galactosamine- induced hepatic failure in mice.
Journal: Biological & pharmaceutical bulletin
Published: May 13, 2014
Protective effect of madecassoside against cognitive impairment induced by D-galactose in mice.
Journal: Pharmacology, biochemistry, and behavior
Published: April 26, 2014
Last Updated: 09/26/2026